Literature DB >> 23179833

Isolation and characterization of cancer stem cells in vitro.

Craig Gedye1, Laurie Ailles.   

Abstract

The cancer stem cell hypothesis is an appealing concept to account for intratumoral heterogeneity and the observation that systemic metastasis and treatment failure are often associated with the survival of a small number of cancer cells. Whilst in vivo evidence forms the foundation of this concept, in vitro methods and reagents are attractive as they offer opportunities to perform experiments that are not possible in an animal model. While there is abundant evidence that existing cancer cell lines are not reliable models of tumor heterogeneity, recent advances based on well validated novel cancer cell lines established de novo in defined serum-free media are encouraging, particularly in the study of glioblastoma multiforme. In this chapter we wish to broadly outline the process of establishing, characterizing, and managing novel cancer cell lines in defined serum-free media, and discuss the limitations and potential opportunities that may arise from these model systems.

Entities:  

Mesh:

Year:  2013        PMID: 23179833     DOI: 10.1007/978-1-62703-128-8_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Crosstalk between M2 macrophages and glioma stem cells.

Authors:  Leora M Nusblat; Molly J Carroll; Charles M Roth
Journal:  Cell Oncol (Dordr)       Date:  2017-06-22       Impact factor: 6.730

2.  [Role of ovarian tumor stem-like cells sorted from human epithelial ovarian cancer SKOV3 cells in vasculogenic mimicry formation].

Authors:  Jun Liang; Huimin Xing; Xiaohua Wu; Lei Zhang; Jun Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

3.  Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.

Authors:  Fortunata Iacopino; Cristiana Angelucci; Roberto Piacentini; Filippo Biamonte; Annunziato Mangiola; Giulio Maira; Claudio Grassi; Gigliola Sica
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

4.  Gene silencing of HIF-2α disrupts glioblastoma stem cell phenotype.

Authors:  Leora M Nusblat; Shaili Tanna; Charles M Roth
Journal:  Cancer Drug Resist       Date:  2020-03-11

5.  Benzidine promotes the stemness of bladder cancer stem cells via activation of the Sonic hedgehog pathway.

Authors:  Dengdian Wang; Dongdong Xie; Liangkuan Bi; Yi Wang; Ci Zou; Lei Chen; Hao Geng; Weiwei Qian; Yuan Li; Hongliang Sun; Xin Wang; Youlu Lu; Dexin Yu; Caiyun Zhong
Journal:  Oncol Lett       Date:  2020-12-23       Impact factor: 2.967

6.  Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity.

Authors:  Craig A Gedye; Ali Hussain; Joshua Paterson; Alannah Smrke; Harleen Saini; Danylo Sirskyj; Keira Pereira; Nazleen Lobo; Jocelyn Stewart; Christopher Go; Jenny Ho; Mauricio Medrano; Elzbieta Hyatt; Julie Yuan; Stevan Lauriault; Mona Meyer; Maria Kondratyev; Twan van den Beucken; Michael Jewett; Peter Dirks; Cynthia J Guidos; Jayne Danska; Jean Wang; Bradly Wouters; Benjamin Neel; Robert Rottapel; Laurie E Ailles
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

7.  Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma.

Authors:  Craig Gedye; Danylo Sirskyj; Nazleen C Lobo; Jalna Meens; Elzbieta Hyatt; Michael Robinette; Neil Fleshner; Robert J Hamilton; Girish Kulkarni; Alexandre Zlotta; Andrew Evans; Antonio Finelli; Michael A S Jewett; Laurie E Ailles
Journal:  Sci Rep       Date:  2016-04-28       Impact factor: 4.379

8.  Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.

Authors:  Nazleen C Lobo; Craig Gedye; Anthony J Apostoli; Kevin R Brown; Joshua Paterson; Natalie Stickle; Michael Robinette; Neil Fleshner; Robert J Hamilton; Girish Kulkarni; Alexandre Zlotta; Andrew Evans; Antonio Finelli; Jason Moffat; Michael A S Jewett; Laurie Ailles
Journal:  BMC Cancer       Date:  2016-07-16       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.